Device Trial Radar · NCT02928289
Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
Last checked: Nov 20, 2026Latest source record: Nov 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
29
Actual
Start
Jan 23, 2017
Primary completion
Jan 17, 2019
Study completion Jan 17, 2019
Sponsor
- Lead sponsor
- Sight Sciences, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 10, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in reducing intraocular pressure (IOP) in adult, pseudophakic subjects with open-angle glaucoma.
Conditions
- Open-Angle Glaucoma
Interventions
VISCO360 ab interno canaloplasty surgeryDevice
360 degrees of viscodilation of Schlemm's canal
Selective Laser Trabeculoplasty (SLT)Device
360 degrees of selective laser trabeculoplasty
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Diurnal IOP at 12 Months (Measured in mm Hg)Time frame: 12 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Vold Vision
Fayetteville, Arkansas
Coastal Vision Medical Group
Orange, California
Dean McGee Eye Institute
Oklahoma City, Oklahoma
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.